These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis. Bei Y; Hua-Huy T; Nicco C; Duong-Quy S; Le-Dong NN; Tiev KP; Chéreau C; Batteux F; Dinh-Xuan AT Exp Lung Res; 2016; 42(1):44-55. PubMed ID: 26873329 [TBL] [Abstract][Full Text] [Related]
28. New insights into CD4(+) T cell abnormalities in systemic sclerosis. Liu M; Wu W; Sun X; Yang J; Xu J; Fu W; Li M Cytokine Growth Factor Rev; 2016 Apr; 28():31-6. PubMed ID: 26724976 [TBL] [Abstract][Full Text] [Related]
29. Strategy for treatment of fibrosis in systemic sclerosis: Present and future. Yanaba K J Dermatol; 2016 Jan; 43(1):46-55. PubMed ID: 26782006 [TBL] [Abstract][Full Text] [Related]
30. Targeting interferons as a strategy for systemic sclerosis treatment. Ciechomska M; Skalska U Immunol Lett; 2018 Mar; 195():45-54. PubMed ID: 29106987 [TBL] [Abstract][Full Text] [Related]
31. Connective tissue diseases: Adipocyte-myofibroblast transition: linking intradermal fat loss to skin fibrosis in SSc. Onuora S Nat Rev Rheumatol; 2015 Feb; 11(2):63. PubMed ID: 25561364 [No Abstract] [Full Text] [Related]
38. The Antifibrotic Effect of α2AP Neutralization in Systemic Sclerosis Dermal Fibroblasts and Mouse Models of Systemic Sclerosis. Kanno Y; Shu E; Kanoh H; Seishima M J Invest Dermatol; 2016 Apr; 136(4):762-769. PubMed ID: 26743600 [TBL] [Abstract][Full Text] [Related]
39. T cell abnormalities in systemic sclerosis with a focus on Th17 cells. Brembilla NC; Chizzolini C Eur Cytokine Netw; 2012; 23(4):128-39. PubMed ID: 23360781 [TBL] [Abstract][Full Text] [Related]
40. Intradermal Injections of Bleomycin to Model Skin Fibrosis. Yamamoto T Methods Mol Biol; 2017; 1627():43-47. PubMed ID: 28836193 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]